Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services through its Contract Research Services (CRS) business, and Fluofarma, a contract research organization specializing in high content analysis, have ...
read more
Tuesday, December 29, 2020
Harbour BioMed and Utrecht University announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the prevention and treatment of COVID-19.
read more
Harbour BioMed and China National Pharmaceutical Group announced a strategic collaboration to establish a joint innovation R&D consortium focused on advancing next-generation biologic therapies.
read more
Harbour BioMed and PPD announced a strategic collaboration to develop HBM’s innovative therapeutics in the fields of oncology and immunology.
read more
HBM and Erasmus MC, University Medical Center Rotterdam have signed a 10-year MOU to enable a range of joint research activities to develop next generation biotherapeutics.
read more
Harbour BioMed and Chia Tai Tianqing announced they are entering into a strategic alliance to discover, develop and commercialize next-generation biologics.
read more
Harbour BioMed has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167.
read more
Medidata a global provider of cloud-based solutions for clinical research, has signed a multi-year enterprise deal with Hanmi Pharmaceutical, one of South Korea's leading drug makers.
read more
Hanmi Fine Chemical (hereinafter Hanmi FC) a subsidiary of Hanmi Pharmaceutical Group specializing in APIs (Active Pharmaceutical Ingredient) development and manufacturing, is now accelerating a new business, expanding its specialties from ongoing ...
read more
Hangzhou Just Biotherapeutics held the grand opening ceremony for its R&D Center and Manufacturing Facility.
read more
Sen-Jam Pharmaceutical has executed a second strategic partnership with KVK Tech. KVK Tech is a Specialty Pharmaceutical Manufacturing company that will now be providing formulation and Chemistry, Manufacturing & Controls (CMC) for Sen-Jam ...
read more
Norwich focuses on manufacturing potent, solid dose products, including fast dissolve and controlled release tablets, while also providing a range of analytical services in-house.
read more
Hammock Pharmaceuticals has announced the execution of a license agreement with MilanaPharm/TriLogic Pharma for the exclusive global rights to their women's health and urology hydrogel technology platform.
read more
Hamilton Health Care System and Baxter International announced Hamilton is the first health system in the U.S. to use Baxter’s new PrisMax system.
read more
Inspirata announced its free remote pathology initiative, available to healthcare institutions looking to provide flexibility to their staff during COVID-19.
read more